Medical Microbiology

chromiumreleaseassay
134
ELISPOTassay 132
hemolyticplaqueassay
132
intracellularcytokine
assay 134
lymphocytestimulation
assay 132 – 133
mixedlymphocytereac-
tions 133 – 134
Lymphocytes 46
isolationof 129 – 132
subtypedistribution 48
seealsoBcells;Lym-
phocytefunctiontests;T
cells
Lymphocyticchoriome-
ningitis(LCM) 1 42,
462 – 464
diagnosis 644
infection/immunere-
sponserelationship 104
Lymphocyticmeningora-
diculitis 327
Lymphogranulomavener-
eum336,338, 339
diagnosis 637
seealsoChlamydiatra-
chomatis
Lymphoidlineage 46
Lymphoidorgans
primary45, 47 , 143
secondary45, 47 , 4 8, 74
antigen-presenting
cells 62
Lymphokine-activated
killercells(LAKcells) 1 20,
142
Lymphokines 77
Lymphoma
Burkitt 424
gastric 638
HIVinfectionand
451 – 453
T-cell 424
Lymphoreticularsystem
infections 648 – 649
seealsospecificinfections
Lymphotoxin 82
Lysogenicbacteria 1 80, 186
Lysogenicconversion 1 80,
186
Lysogeny 186
Lyssaviruses 467
diagnosis 645
epidemiology 469
Lysteriolysin 16

&M

Machupovirus 463 – 464

Macrolides 191

mechanismofaction 198

Macrophageinflammatory

protein(MIP) 82

Macrophage-derivedche-

mokine(MDC) 83

Macrophages 21

disablement 13

Madurafoot 27 3,355, 372

diagnosis 652

Madurella 372

diagnosis 652

mycetomi 355

Majorhistocompatibility

complex(MHC) 58 – 63,

142

consequencesofMHC

variety 63

functions 60 – 62

antigenpresentation

60 – 62

MHCclassImolecules

59, 61 , 75

proteinstructure 60

MHCclassIImolecules

59, 61 , 72 – 75

MHCclassIIImolecules

59

MHCrestriction58, 142

transplantrejectionand

115 , 117

Malaria 520 – 537

clinicalmanifestations

526 – 527

classicmalarialpar-

oxysm 527

courseofinfection 527

febrilepatterns

526 – 527

incubationperiods

526

onsetsymptoms 526

recurrence 527

diagnosis 531 ,625, 649

bloodspecimen

handling 622

differentialdiagnosis

524, 525

diseasecontrol 537

distribution 521

epidemiology 530 – 531

immunity 530

occurrence 520

parasites 520 – 521

pathogenesisand

pathology 528 – 530

anemia 529

cytoadherenceand

rosetteformation 529

cytokinerole

528 – 529

prevention 534 – 537

chemoprophylaxis

535, 536 – 537

emergencystand-by

treatment 536 – 537

mosquitobitepreven-

tion 535 – 536

resistance 530

therapy 531 – 534

acutedisease 532

drugresistance 532

relapseprevention

532

typesof 527 – 528

malignanttertian

(tropica) 521 , 528

mixedinfections 528

quartan 521 , 527

tertian520, 527

seealsoPlasmodium

Malassezia 369

furfur355, 37 0, 374

Malleus 310 – 311

diagnosis 648

Mandibulata 606

Manifestationindex 27

Mansonella 593

ozzardi589, 592

perstans589, 592

streptocerca 589

Mantouxskintest99, 266

Marburgvirus 471

clinicalpicture 471

diagnosis 471 , 650

epidemiology 471

pathogenesis 471

prevention 471

Mastadenovirus 382

Mayarovirus 441

Measles465, 466

diagnosis 63 2, 6 45, 650

eyeinfections655, 656

exanthem 466

Germanmeasles 441 ,

650, 656

prevention 467

Medicalmicrobiology 629

Medinaworm 596

Mediterraneanfever 332

Mefloquine533, 535

Melioidosis 311

682 LLymphocytefunctiontests

All rights reserved. Usage subject to terms and conditions of license

Kayser, Medical Microbiology © 2005 Thieme

All rights reserved. Usage subject to terms and conditions of license.